Advancing the management of MDS and AML: Novel immune-based approaches
touchEXPERT OPINIONS for touchONCOLOGY
Listen to three experts describe the role of immune dysregulation in myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML), and summarize the rationale and available data for emerging immune-based therapeutic strategies. In a short panel discussion, they consider the possible impact these therapies may have on future clinical practice.
The experts
Prof. Dr. med. Uwe Platzbecker — University Hospital Leipzig, Leipzig, Germany
Prof. Agnieszka Wierzbowska — Medical University of Łódź, Copernicus Memorial Hospital, Łódź, Poland
Prof. Valeria…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.